GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,192,000 | +1074.1% | 399,290 | +450.7% | 0.01% | +1200.0% |
| Q2 2022 | $2,316,000 | -6.8% | 72,500 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $2,484,000 | +18.7% | 71,702 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $2,093,000 | +13.1% | 71,502 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $1,850,000 | -27.3% | 72,602 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,543,000 | +128.3% | 72,602 | +165.6% | 0.00% | – |
| Q1 2021 | $1,114,000 | -31.7% | 27,335 | -27.4% | 0.00% | -100.0% |
| Q4 2020 | $1,630,000 | -21.8% | 37,637 | -0.4% | 0.00% | 0.0% |
| Q3 2020 | $2,084,000 | -25.3% | 37,791 | -14.5% | 0.00% | -50.0% |
| Q2 2020 | $2,789,000 | -57.3% | 44,184 | -65.5% | 0.00% | -60.0% |
| Q1 2020 | $6,534,000 | -35.2% | 127,900 | +0.9% | 0.01% | -16.7% |
| Q4 2019 | $10,079,000 | +154.9% | 126,800 | +55.6% | 0.01% | +200.0% |
| Q3 2019 | $3,954,000 | -7.8% | 81,500 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $4,287,000 | +9.2% | 81,500 | +9.8% | 0.00% | 0.0% |
| Q1 2019 | $3,927,000 | +30.5% | 74,200 | +1.2% | 0.00% | +50.0% |
| Q4 2018 | $3,009,000 | +8.0% | 73,300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,785,000 | -14.9% | 73,300 | +1.2% | 0.00% | 0.0% |
| Q2 2018 | $3,272,000 | +22.0% | 72,400 | +30.5% | 0.00% | 0.0% |
| Q1 2018 | $2,681,000 | +23.4% | 55,500 | +0.5% | 0.00% | 0.0% |
| Q4 2017 | $2,172,000 | -7.0% | 55,200 | -26.6% | 0.00% | 0.0% |
| Q3 2017 | $2,335,000 | -58.4% | 75,200 | -63.4% | 0.00% | -50.0% |
| Q2 2017 | $5,612,000 | +542.8% | 205,200 | +765.8% | 0.00% | +300.0% |
| Q1 2017 | $873,000 | +111.9% | 23,700 | -16.8% | 0.00% | – |
| Q4 2016 | $412,000 | -37.3% | 28,500 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $657,000 | +55.0% | 28,500 | +11.6% | 0.00% | – |
| Q2 2016 | $424,000 | -50.4% | 25,546 | -3.3% | 0.00% | -100.0% |
| Q4 2015 | $854,000 | +15.7% | 26,416 | +50.8% | 0.00% | 0.0% |
| Q3 2015 | $738,000 | – | 17,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |